In vitro evaluation of Resveratrol as a potential pre-exposure prophylactic drug against Trypanosoma cruzi infection
Chagas' disease or American trypanosomiasis, caused by Trypanosoma cruzi infection, is an endemic disease in Latin America, which has spread worldwide in the past years. The drugs presently used for treatment have shown limited efficacy due to the appearance of resistant parasites and severe si...
Main Authors: | Matías E. Rodriguez, Valeria Tekiel, Vanina A. Campo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | International Journal for Parasitology: Drugs and Drug Resistance |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211320722000203 |
Similar Items
-
Efficacy of sertraline against Trypanosoma cruzi: an in vitro and in silico study
by: Daiane Dias Ferreira, et al.
Published: (2018-10-01) -
Biology of Trypanosoma cruzi: An update Biología del Trypanosoma cruzi: Actualización
by: André Vianna Martins, et al.
Published: (2012-03-01) -
Kinetics of Trypanosoma cruzi destruction in the mouse spleen
by: Zulmira M.S. Cordeiro, et al.
Published: (1997-02-01) -
In vitro activity of Etanidazole against the protozoan parasite Trypanosoma cruzi
by: Patricia B Petray, et al.
Published: (2004-03-01) -
Review on Experimental Treatment Strategies Against Trypanosoma cruzi
by: Mazzeti AL, et al.
Published: (2021-03-01)